Table 1. Open in new tab Characteristics...

Table 1.

Characteristics of the Patients With Cholera Used for the Immunoscreen

Patient	Infecting Strain	Age, y	Sex	ABO Blood Group	Vibriocidal Inaba D2^a	Vibriocidal Ogawa D2^a	Vibriocidal Inaba D7^a	Vibriocidal Ogawa D7^a	Vibriocidal Inaba D30^a	Vibriocidal Ogawa D30^a
1	O1-Inaba	46	F	B+	40	20	640	640	640	320
2	O1-Inaba	36	M	O+	40	20	640	1280	640	640
3	O1-Inaba	40	F	O+	10	5	2560	2560	2560	320
4	O1-Ogawa	30	M	O+	10	40	1280	5120	640	5120
5	O1-Ogawa	44	F	B+	5	5	5120	5120	2560	1280
6	O1-Ogawa	50	M	O+	20	40	10240	10240	1280	5120
7	O1-Ogawa	21	F	B+	5	40	5120	10240	2560	2560

Patient	Infecting Strain	Age, y	Sex	ABO Blood Group	Vibriocidal Inaba D2^a	Vibriocidal Ogawa D2^a	Vibriocidal Inaba D7^a	Vibriocidal Ogawa D7^a	Vibriocidal Inaba D30^a	Vibriocidal Ogawa D30^a
1	O1-Inaba	46	F	B+	40	20	640	640	640	320
2	O1-Inaba	36	M	O+	40	20	640	1280	640	640
3	O1-Inaba	40	F	O+	10	5	2560	2560	2560	320
4	O1-Ogawa	30	M	O+	10	40	1280	5120	640	5120
5	O1-Ogawa	44	F	B+	5	5	5120	5120	2560	1280
6	O1-Ogawa	50	M	O+	20	40	10240	10240	1280	5120
7	O1-Ogawa	21	F	B+	5	40	5120	10240	2560	2560

^aVibriocidal titer to Vibrio cholerae serotypes Ogawa (strain 25049) and Inaba (strain T-19479) as defined as the reciprocal of the highest plasma dilution resulting in >50% reduction in V. cholerae O1 growth (measured by optical density) compared to control wells without plasma.

This Feature Is Available To Subscribers Only